After listening to the conference call, it was
apparent from the questions/answers that all the analysts
were very excited by the quarter and the rollout for
the next 6 - 12 months. When a stock goes up during a
conference call, I have found that to be a superb long term
indicator. After see the quarter and listening to the call,
I cannot imagine that anyone would want to sell
their HOLX at these price levels. It appears quite
obvious to me that as more people discover this microcap,
there will be many more buyers then sellers, thus, a
higher stock price.
Just listened to the conference call. One word:
This company is a home run just waiting
to happen. IMO, without a doubt, DRC is worth well
more then the $100 million market capitalization of
HOLX. My guestimate would be more on the order of $500
million for DRC alone. They have a superb and growing
backlog and have hardly begun the selling game. They just
signed their first national distributor for the retrofit
portion of these sales, plates and systems are in
addition to this. They will be doubling their sales force
because they cannot cope with the existing
Add to this a profitable bone densitometer business
and $59,000,000 in cash.
Bottom line: the
market capitalization of HOLX will not remain at $100
million much longer - a pending home run IMHO.
Happy to say I was dead wrong in my post
yesterday. I was looking for a depressing quarter based upon
the way the stock has been trading the past few
weeks. Nothing depressing about this quarter, very
upbeat across the board. There is nothing not to like
that I see.
I guess the recent HOLX stock
activity was simply "the market" for medical tech which
has been taking a beating. I know some colleages that
want to accumulate more of this stock, IMO they may
have missed their opportunity to buy incredibly cheap
the past couple of days.
Agree with that assessment, I think we've just
seen the lows this stock will ever see.
impressed with the backlog on the new Delphi and even more
impressed with the backlog on the new direct-to-digital
radiographic products. Total backlog $14m, which the company
states is a record, split 50/50 between old business and
Despite the very large
investment being made, the company is doing a fine job
maintaining its stockholder's equity. When DRC turns the
corner, I believe we will be looking at a $50+ stock and
the current stockholders will have a wonderful ride
throughout 2000 and beyond.
Looking forward to the
conference call to verify my optimism.
The numbers are out - the quarter is MUCH better
then I expected to see. Without DRC, the company would
have made 5c per diluted share (in other words, the
stock would be trading well over its $10 book value if
investors understood what was going on here). R&D spending
is very heavy. Terrific backlog on both the older
core bone densitometer business and on the new digital
x-ray as well. I think once this report is fully
digested, we will see some large buyers stepping up to the
plate over the next few weeks. Wonder if we'll be able
to nibble at some more under $7 - doubt it...
Yes, check the Yahoo news - it lists the info on
the conf call.
What does everybody expect? I'm
looking for results similar to Q1 -- $21m rev, 19c loss,
with perhaps some annoucements on DRC (OEMs, etc..). I
think the street is expecting crap based upon the stock
price trading well under book and slightly over cash --
so it sure looks like the bad news is factored into
HOLX (as is normally the case). Would be tough for
them to disappoint much further from this level! Any
postives IMO would easily blow the stock over $10 -- if
not this quarter (I'm not expecting it), then in Q3